Page last updated: 2024-09-03

pivaloylcarnitine and 3-methylbutyrylcarnitine

pivaloylcarnitine has been researched along with 3-methylbutyrylcarnitine in 2 studies

Compound Research Comparison

Studies
(pivaloylcarnitine)
Trials
(pivaloylcarnitine)
Recent Studies (post-2010)
(pivaloylcarnitine)
Studies
(3-methylbutyrylcarnitine)
Trials
(3-methylbutyrylcarnitine)
Recent Studies (post-2010) (3-methylbutyrylcarnitine)
26172906

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdenur, JE; Chamoles, NA; Fuertes, AN; Guinle, AE; Schenone, AB1
Janzen, N; Peter, M; Sander, J; Sander, S; Steuerwald, U; Terhardt, M1

Other Studies

2 other study(ies) available for pivaloylcarnitine and 3-methylbutyrylcarnitine

ArticleYear
Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme.
    Journal of inherited metabolic disease, 1998, Volume: 21, Issue:6

    Topics: Carnitine; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Hemiterpenes; Humans; Infant, Newborn; Mass Spectrometry; Metabolism, Inborn Errors; Neonatal Screening; Pentanoic Acids; Sulbactam; Urinary Tract Infections

1998
UPLC-MS/MS analysis of C5-acylcarnitines in dried blood spots.
    Clinica chimica acta; international journal of clinical chemistry, 2013, Jun-05, Volume: 421

    Topics: Amino Acid Metabolism, Inborn Errors; Carnitine; Chromatography, High Pressure Liquid; Diagnosis, Differential; Dried Blood Spot Testing; Humans; Infant, Newborn; Isovaleryl-CoA Dehydrogenase; Limit of Detection; Neonatal Screening; Reproducibility of Results; Tandem Mass Spectrometry

2013